Trimarchi Thomas

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Trimarchi Thomas's trades of BridgeBio Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
143.35
Quantity 4,050 -1.3%
Value US$974,647
Transaction date
Planned sale
Price
173.96
Quantity 82,617 +10.4%
Value US$3,400,295
Transaction date
Proposed sale
Price
340.12
Quantity 54,784
Value US$3,007,301
Transaction date
Planned sale
Price
75.38
Quantity 200 -0.1%
Value US$15,076
Transaction date
Planned sale
Price
74.71
Quantity 13,400 -3.8%
Value US$1,001,071
Transaction date
Proposed sale
Price
74.72
Quantity 13,600
Value US$1,016,147
Transaction date
Planned sale
Price
66.84
Quantity 6,956 -1.8%
Value US$464,938
Transaction date
Planned sale
Price
66.19
Quantity 9,978 -2.5%
Value US$660,467
Transaction date
Proposed sale
Price
66.46
Quantity 16,934
Value US$1,125,403
Transaction date
Proposed sale
Price
49.48
Quantity 42,237
Value US$2,090,077
Transaction date
Planned sale
Price
50.94
Quantity 1,973 -0.4%
Value US$100,512
Transaction date
Planned sale
Price
50.14
Quantity 15,380 -3.2%
Value US$771,210
Transaction date
Proposed sale
Price
50.23
Quantity 17,353
Value US$871,723
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-18
PlS Planned sale
4,050 -1.3%
143.35
US$974,647 		4,050 -1.3% 143.35 US$974,647
2026-05-19 2026-05-18
PlS Planned sale
82,617 +10.4%
173.96
US$3,400,295 		82,617 +10.4% 173.96 US$3,400,295
2026-05-18 2026-05-18
PrS Proposed sale
54,784
340.12
US$3,007,301 		54,784 340.12 US$3,007,301
2026-02-18 2026-02-17
PlS Planned sale
200 -0.1%
75.38
US$15,076 		200 -0.1% 75.38 US$15,076
2026-02-18 2026-02-17
PlS Planned sale
13,400 -3.8%
74.71
US$1,001,071 		13,400 -3.8% 74.71 US$1,001,071
2026-02-17 2026-02-17
PrS Proposed sale
13,600
74.72
US$1,016,147 		13,600 74.72 US$1,016,147
2025-11-18 2025-11-17
PlS Planned sale
6,956 -1.8%
66.84
US$464,938 		6,956 -1.8% 66.84 US$464,938
2025-11-18 2025-11-17
PlS Planned sale
9,978 -2.5%
66.19
US$660,467 		9,978 -2.5% 66.19 US$660,467
2025-11-17 2025-11-17
PrS Proposed sale
16,934
66.46
US$1,125,403 		16,934 66.46 US$1,125,403
2025-08-22 2025-08-21
S Sale
42,237 -9.1%
49.48
US$2,090,081 		42,237 -9.1% 49.48 US$2,090,081
2025-08-21 2025-08-21
PrS Proposed sale
42,237
49.48
US$2,090,077 		42,237 49.48 US$2,090,077
2025-08-19 2025-08-18
PlS Planned sale
1,973 -0.4%
50.94
US$100,512 		1,973 -0.4% 50.94 US$100,512
2025-08-19 2025-08-18
PlS Planned sale
15,380 -3.2%
50.14
US$771,210 		15,380 -3.2% 50.14 US$771,210
2025-08-18 2025-08-18
PrS Proposed sale
17,353
50.23
US$871,723 		17,353 50.23 US$871,723